{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:38:51Z","timestamp":1794847131613,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["AS-PG-19b-010"],"award-info":[{"award-number":["AS-PG-19b-010"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Understanding the genetic architecture of the circulating proteome can help determine if a protein is causally linked to disease. Previous large-scale genome-wide association studies of proteins have mostly been conducted on pre-defined, targeted subsets of the proteome, and have often concentrated on low-abundance proteins, many of which don\u2019t exert their main function in serum. Mass spectrometry-based proteomics facilitates the study of high-abundance proteins and their isoforms, focusing on proteins active in blood. In 15035 individuals from Generation Scotland, we perform genome-wide association studies of 439 highly abundant serum protein groups as identified and quantified by liquid chromatography tandem mass spectrometry. We identify 1553 independent SNP signals for 398 proteins (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20091.2\u00d710\n                    <jats:sup>\u221210<\/jats:sup>\n                    ). Two-sample Mendelian Randomisation analyses are applied to test if the 398 proteins with significant SNP signals are causally associated with 79 common causes of morbidity and mortality. We report putative causal associations between 13 proteins and 17 outcomes, including neuropsychiatric and cardiovascular conditions. Large-scale genome-wide analyses of the high-abundance proteome complement targeted approaches for the discovery of causal pathways of disease.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76474-8","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:34:00Z","timestamp":1788964440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide analysis of 439 mass spectrometry-based proteomic profiles in a population of 15,035 Scottish individuals"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-510X","authenticated-orcid":false,"given":"Anne","family":"Richmond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8575","authenticated-orcid":false,"given":"Josephine A.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Hillary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksej","family":"Zelezniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Vernardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-318X","authenticated-orcid":false,"given":"Aleksandra D.","family":"Chybowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturas","family":"Grauslys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jure","family":"Mur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0198-5078","authenticated-orcid":false,"given":"Archie","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0089-2571","authenticated-orcid":false,"given":"Camilla","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poppy","family":"Adkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Brigden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph B.","family":"Messner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Porteous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-9550","authenticated-orcid":false,"given":"Caroline","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-4588","authenticated-orcid":false,"given":"Andrew M.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-7413","authenticated-orcid":false,"given":"Markus","family":"Ralser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-4260","authenticated-orcid":false,"given":"Riccardo E.","family":"Marioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"76474_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson, N. L. & Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteom. 1, 845\u2013867 (2002).","journal-title":"Mol. Cell Proteom."},{"key":"76474_CR2","doi-asserted-by":"crossref","unstructured":"Mingels, A. M., Mills, N. L., Mueller, C., & on behalf of the Study Group on Biomarkers of the ESC Association for Acute CardioVascular Care. Cardiac troponin T and I: back to basics. Eur. Heart J. Acute Cardiovasc. Care 12, 631\u2013632 (2023).","DOI":"10.1093\/ehjacc\/zuad084"},{"key":"76474_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/14737159.2020.1768849","volume":"20","author":"SW Benoit","year":"2020","unstructured":"Benoit, S. W., Ciccia, E. A. & Devarajan, P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev. Mol. Diagn. 20, 1019\u20131026 (2020).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"76474_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"G Cem","year":"1999","unstructured":"Cem, G. & Irving, K. Acute-Phase Proteins and Other Systemic Responses to Inflammation. N. Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"key":"76474_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc2351","volume":"8","author":"H Lilja","year":"2008","unstructured":"Lilja, H., Ulmert, D. & Vickers, A. J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 8, 268\u2013278 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"76474_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre, K., McCarthy, M. I. & Schwenk, J. M. Genetics meets proteomics: perspectives for large population-based studies. Nat. Rev. Genet. 22, 19\u201337 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"76474_CR7","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9, e95192 (2014).","journal-title":"PLoS ONE"},{"key":"76474_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"76474_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41588-025-02089-2","volume":"57","author":"L Niu","year":"2025","unstructured":"Niu, L. et al. Plasma proteome variation and its genetic determinants in children and adolescents. Nat. Genet. 57, 635\u2013646 (2025).","journal-title":"Nat. Genet."},{"key":"76474_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"76474_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"76474_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).","journal-title":"Science"},{"key":"76474_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao, J. H. et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat. Immunol. 24, 1540\u20131551 (2023).","journal-title":"Nat. Immunol."},{"key":"76474_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nrd2006","volume":"5","author":"SF Kingsmore","year":"2006","unstructured":"Kingsmore, S. F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310\u2013321 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76474_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202200013","volume":"23","author":"CB Messner","year":"2023","unstructured":"Messner, C. B. et al. Mass spectrometry-based high-throughput proteomics and its role in biomedical studies and systems biology. Proteomics 23, 2200013 (2023).","journal-title":"Proteomics"},{"key":"76474_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201900278","volume":"20","author":"LM Raffield","year":"2020","unstructured":"Raffield, L. M. et al. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics 20, e1900278 (2020).","journal-title":"Proteomics"},{"key":"76474_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36491-3","volume":"14","author":"F Xu","year":"2023","unstructured":"Xu, F. et al. Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility. Nat. Commun. 14, 896 (2023).","journal-title":"Nat. Commun."},{"key":"76474_CR18","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/s41588-025-02413-w","volume":"57","author":"K Suhre","year":"2025","unstructured":"Suhre, K. et al. A genome-wide association study of mass spectrometry proteomics using a nanoparticle enrichment platform. Nat. Genet. 57, 2987\u20132996 (2025).","journal-title":"Nat. Genet."},{"key":"76474_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41587-021-00860-4","volume":"39","author":"CB Messner","year":"2021","unstructured":"Messner, C. B. et al. Ultra-fast proteomics with Scanning SWATH. Nat. Biotechnol. 39, 846\u2013854 (2021).","journal-title":"Nat. Biotechnol."},{"key":"76474_CR20","doi-asserted-by":"publisher","first-page":"e1000981","DOI":"10.1371\/journal.pgen.1000981","volume":"6","author":"G Par\u00e9","year":"2010","unstructured":"Par\u00e9, G., Cook, N. R., Ridker, P. M. & Chasman, D. I. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women\u2019s Genome Health Study. PLoS Genet. 6, e1000981 (2010).","journal-title":"PLoS Genet"},{"key":"76474_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw3538","volume":"5","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Genotype-by-environment interactions inferred from genetic effects on phenotypic variability in the UK Biobank. Sci. Adv. 5, eaaw3538 (2019).","journal-title":"Sci. Adv."},{"key":"76474_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","volume":"620","author":"K Trajanoska","year":"2023","unstructured":"Trajanoska, K. et al. From target discovery to clinical drug development with human genetics. Nature 620, 737\u2013745 (2023).","journal-title":"Nature"},{"key":"76474_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","volume":"629","author":"EV Minikel","year":"2024","unstructured":"Minikel, E. V., Painter, J. L., Dong, C. C. & Nelson, M. R. Refining the impact of genetic evidence on clinical success. Nature 629, 624\u2013629 (2024).","journal-title":"Nature"},{"key":"76474_CR24","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2022","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638 (2022).","journal-title":"Nucleic Acids Res."},{"key":"76474_CR25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","volume":"105","author":"SM Janciauskiene","year":"2011","unstructured":"Janciauskiene, S. M. et al. The discovery of \u03b11-antitrypsin and its role in health and disease. Respir. Med. 105, 1129\u20131139 (2011).","journal-title":"Respir. Med."},{"key":"76474_CR26","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3390\/ijms23052441","volume":"23","author":"ME O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, M. E. et al. A review of alpha-1 antitrypsin binding partners for immune regulation and potential therapeutic application. Int. J. Mol. Sci. 23, 2441 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"76474_CR27","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMra1910234","volume":"382","author":"P Strnad","year":"2020","unstructured":"Strnad, P., McElvaney, N. G. & Lomas, D. A. Alpha1-antitrypsin deficiency. N. Engl. J. Med. 382, 1443\u20131455 (2020).","journal-title":"N. Engl. J. Med."},{"key":"76474_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/metabo11100690","volume":"11","author":"J Behbodikhah","year":"2021","unstructured":"Behbodikhah, J. et al. Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target. Metabolites 11, 690 (2021).","journal-title":"Metabolites"},{"key":"76474_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s43042-021-00135-2","volume":"22","author":"S Ashiq","year":"2021","unstructured":"Ashiq, S. & Ashiq, K. The association of apolipoprotein-E (APOE) gene polymorphisms with coronary artery disease: a systematic review and meta-analysis. Egypt. J. Med. Hum. Genet. 22, 16 (2021).","journal-title":"J. Med. Hum. Genet."},{"key":"76474_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/appi.focus.24022004","volume":"22","author":"HK Hughes","year":"2024","unstructured":"Hughes, H. K., Moreno, R. J. & Ashwood, P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Focus 22, 229\u2013241 (2024).","journal-title":"Focus"},{"key":"76474_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-024-02778-2","volume":"14","author":"O Iakunchykova","year":"2024","unstructured":"Iakunchykova, O., Leonardsen, E. H. & Wang, Y. Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we? Transl. Psychiatry 14, 1\u201311 (2024).","journal-title":"Transl. Psychiatry"},{"key":"76474_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1369\/0022155420940067","volume":"68","author":"MS Lord","year":"2020","unstructured":"Lord, M. S., Melrose, J., Day, A. J. & Whitelock, J. M. The inter-\u03b1-trypsin inhibitor family: versatile molecules in biology and pathology. J. Histochem. Cytochem. 68, 907\u2013927 (2020).","journal-title":"J. Histochem. Cytochem."},{"key":"76474_CR33","first-page":"289","volume":"5","author":"S Song","year":"2018","unstructured":"Song, S. Alpha-1 antitrypsin therapy for autoimmune disorders. Chronic Obstr. Pulm. Dis. J. 5, 289\u2013301 (2018).","journal-title":"Chronic Obstr. Pulm. Dis. J."},{"key":"76474_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41537-017-0013-9","volume":"3","author":"B Birur","year":"2017","unstructured":"Birur, B., Kraguljac, N. V., Shelton, R. C. & Lahti, A. C. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder\u2014a systematic review of the magnetic resonance neuroimaging literature. npj Schizophr. 3, 15 (2017).","journal-title":"npj Schizophr."},{"key":"76474_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S1474-4422(15)00050-2","volume":"14","author":"C Ecker","year":"2015","unstructured":"Ecker, C., Bookheimer, S. Y. & Murphy, D. G. M. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 14, 1121\u20131134 (2015).","journal-title":"Lancet Neurol."},{"key":"76474_CR36","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41380-023-02293-8","volume":"28","author":"MJ Owen","year":"2023","unstructured":"Owen, M. J., Legge, S. E., Rees, E., Walters, J. T. R. & O\u2019Donovan, M. C. Genomic findings in schizophrenia and their implications. Mol. Psychiatry 28, 3638\u20133647 (2023).","journal-title":"Mol. Psychiatry"},{"key":"76474_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"S Ripke","year":"2013","unstructured":"Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150\u20131159 (2013).","journal-title":"Nat. Genet."},{"key":"76474_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/mp.2012.67","volume":"18","author":"ML Hamshere","year":"2013","unstructured":"Hamshere, M. L. et al. Genome-wide significant associations in schizophrenia to ITIH3\/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 18, 708\u2013712 (2013).","journal-title":"Mol. Psychiatry"},{"key":"76474_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"76474_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"key":"76474_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01195-5","volume":"11","author":"X Yao","year":"2021","unstructured":"Yao, X. et al. Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders. Transl. Psychiatry 11, 1\u201312 (2021).","journal-title":"Transl. Psychiatry"},{"key":"76474_CR42","first-page":"1103","volume":"10","author":"A Cortelazzo","year":"2016","unstructured":"Cortelazzo, A. et al. Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidation. Proteomics 10, 1103\u20131112 (2016).","journal-title":"Proteomics"},{"key":"76474_CR43","first-page":"1700085","volume":"12","author":"L Shen","year":"2018","unstructured":"Shen, L. et al. iTRAQ-based proteomic analysis reveals protein profile in plasma from children with autism. Proteomics 12, 1700085 (2018).","journal-title":"Proteomics"},{"key":"76474_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12986-0","volume":"7","author":"MK Chan","year":"2017","unstructured":"Chan, M. K. et al. Associations between SNPs and immune-related circulating proteins in schizophrenia. Sci. Rep. 7, 12586 (2017).","journal-title":"Sci. Rep."},{"key":"76474_CR45","doi-asserted-by":"publisher","first-page":"111148","DOI":"10.1016\/j.mad.2019.111148","volume":"183","author":"N Gorl\u00e9","year":"2019","unstructured":"Gorl\u00e9, N. & Vandenbroucke, R. E. Interferons: a molecular switch between damage and repair in ageing and Alzheimer\u2019s disease. Mech. Ageing Dev. 183, 111148 (2019).","journal-title":"Mech. Ageing Dev."},{"key":"76474_CR46","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.arr.2021.101409","volume":"70","author":"K-M Wu","year":"2021","unstructured":"Wu, K.-M. et al. The role of the immune system in Alzheimer\u2019s disease. Ageing Res. Rev. 70, 101409 (2021).","journal-title":"Ageing Res. Rev."},{"key":"76474_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358\u2013372 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"76474_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13195-018-0412-9","volume":"10","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Abud, E. M., Snigdha, S. & Agrawal, A. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism. Alzheimers Res. Ther. 10, 81 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"76474_CR49","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.neurobiolaging.2009.08.011","volume":"32","author":"A Marcello","year":"2011","unstructured":"Marcello, A. et al. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate A\u03b2 in plasma of patients with Alzheimer\u2019s disease. Neurobiol. Aging 32, 1379\u20131387 (2011).","journal-title":"Neurobiol. Aging"},{"key":"76474_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/15333175231220166","volume":"38","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Serum protein-based profiles for the diagnostic model of Alzheimer\u2019s disease. Am. J. Alzheimers Dis. Dement. \u00ae 38, 15333175231220166 (2023).","journal-title":"Am. J. Alzheimers Dis. Dement. \u00ae"},{"key":"76474_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10793-w","volume":"12","author":"R Lekhraj","year":"2022","unstructured":"Lekhraj, R. et al. Altered abundances of human immunoglobulin M and immunoglobulin G subclasses in Alzheimer\u2019s disease frontal cortex. Sci. Rep. 12, 6934 (2022).","journal-title":"Sci. Rep."},{"key":"76474_CR52","doi-asserted-by":"publisher","first-page":"100577","DOI":"10.1016\/j.mcpro.2023.100577","volume":"22","author":"JM Bader","year":"2023","unstructured":"Bader, J. M., Albrecht, V. & Mann, M. MS-based proteomics of body fluids: the end of the beginning. Mol. Cell. Proteom. 22, 100577 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"76474_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27164-0","volume":"12","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat. Commun. 12, 6822 (2021).","journal-title":"Nat. Commun."},{"key":"76474_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45233-y","volume":"15","author":"K Suhre","year":"2024","unstructured":"Suhre, K. et al. Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping. Nat. Commun. 15, 989 (2024).","journal-title":"Nat. Commun."},{"key":"76474_CR55","unstructured":"Integrating Mass Spectrometry and Affinity-Based Proteomics. https:\/\/olink.com\/blog\/mass-spectrometry-and-affinity-proteomics-roundtable (2025)."},{"key":"76474_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/pr1008515","volume":"10","author":"S Surinova","year":"2011","unstructured":"Surinova, S. et al. On the development of plasma protein biomarkers. J. Proteome Res. 10, 5\u201316 (2011).","journal-title":"J. Proteome Res."},{"key":"76474_CR57","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"76474_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.trac.2017.05.014","volume":"93","author":"JP da Costa","year":"2017","unstructured":"da Costa, J. P., Santos, P. S. M., Vitorino, R., Rocha-Santos, T. & Duarte, A. C. How low can you go? A current perspective on low-abundance proteomics. Trends Anal. Chem. 93, 171\u2013182 (2017).","journal-title":"Trends Anal. Chem."},{"key":"76474_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/ije\/dys084","volume":"42","author":"BH Smith","year":"2013","unstructured":"Smith, B. H. et al. Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int. J. Epidemiol. 42, 689\u2013700 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"76474_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-14-38","volume":"14","author":"SM Kerr","year":"2013","unstructured":"Kerr, S. M. et al. Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health Study. BMC Med. Genet. 14, 38 (2013).","journal-title":"BMC Med. Genet."},{"key":"76474_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0414-4","volume":"9","author":"R Nagy","year":"2017","unstructured":"Nagy, R. et al. Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants. Genome Med. 9, 23 (2017).","journal-title":"Genome Med."},{"key":"76474_CR62","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"RM Durbin","year":"2010","unstructured":"Durbin, R. M. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061\u20131073 (2010).","journal-title":"Nature"},{"key":"76474_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1605-2","volume":"16","author":"C Amador","year":"2015","unstructured":"Amador, C. et al. Recent genomic heritage in Scotland. BMC Genomics 16, 437 (2015).","journal-title":"BMC Genomics"},{"key":"76474_CR64","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279\u20131283 (2016).","journal-title":"Nat. Genet."},{"key":"76474_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","volume":"11","author":"CB Messner","year":"2020","unstructured":"Messner, C. B. et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 11, 11\u201324.e4 (2020).","journal-title":"Cell Syst."},{"key":"76474_CR66","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1210\/clinem\/dgad031","volume":"108","author":"SI Vernardis","year":"2023","unstructured":"Vernardis, S. I. et al. The impact of acute nutritional interventions on the plasma proteome. J. Clin. Endocrinol. Metab. 108, 2087\u20132098 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76474_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"76474_CR68","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1074\/mcp.RA118.001288","volume":"18","author":"R Bruderer","year":"2019","unstructured":"Bruderer, R. et al. Analysis of 1508 plasma samples by capillary-flow data-independent acquisition profiles proteomics of weight loss and maintenance. Mol. Cell Proteom. 18, 1242\u20131254 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"76474_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-0972-2","volume":"12","author":"M Rusilowicz","year":"2016","unstructured":"Rusilowicz, M., Dickinson, M., Charlton, A., O\u2019Keefe, S. & Wilson, J. A batch correction method for liquid chromatography\u2013mass spectrometry data that does not depend on quality control samples. Metabolomics 12, 56 (2016).","journal-title":"Metabolomics"},{"key":"76474_CR70","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"76474_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76\u201382 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"76474_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng.2213","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369\u2013375 (2012).","journal-title":"Nat. Genet."},{"key":"76474_CR73","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41588-021-00912-0","volume":"53","author":"E Bernabeu","year":"2021","unstructured":"Bernabeu, E. et al. Sex differences in genetic architecture in the UK Biobank. Nat. Genet. 53, 1283\u20131289 (2021).","journal-title":"Nat. Genet."},{"key":"76474_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43856-025-00856-0","volume":"5","author":"N Dordevic","year":"2025","unstructured":"Dordevic, N. et al. Extensive modulation of the circulating blood proteome by hormonal contraceptive use across two population studies. Commun. Med. 5, 131 (2025).","journal-title":"Commun. Med."},{"key":"76474_CR75","doi-asserted-by":"crossref","unstructured":"Zhong, W., Chhibber, A., Luo, L., Mehrotra, D. V. & Shen, J. A fast and powerful linear mixed model approach for genotype-environment interaction tests in large-scale GWAS. Brief. Bioinform. 24, bbac547 (2022).","DOI":"10.1093\/bib\/bbac547"},{"key":"76474_CR76","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).","journal-title":"eLife"},{"key":"76474_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27850-z","volume":"13","author":"A Gudjonsson","year":"2022","unstructured":"Gudjonsson, A. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Commun. 13, 480 (2022).","journal-title":"Nat. Commun."},{"key":"76474_CR78","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","volume":"617","author":"E Pairo-Castineira","year":"2023","unstructured":"Pairo-Castineira, E. et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature 617, 764\u2013768 (2023).","journal-title":"Nature"},{"key":"76474_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Smith, G. D. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).","journal-title":"PLoS Genet."},{"key":"76474_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."},{"key":"76474_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).","journal-title":"Nat. Commun."},{"key":"76474_CR82","doi-asserted-by":"publisher","unstructured":"Richmond A. et al. Genome-wide analysis of 439 mass spectrometry-based proteomic profiles in a population of 15,035 Scottish individuals. marioni-group\/Generation_Scotland_Protein_GWAS https:\/\/doi.org\/10.5281\/zenodo.20082557 (2026).","DOI":"10.5281\/zenodo.20082557"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76474-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:05:13Z","timestamp":1794845113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76474-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76474"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76474-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the funding section the grant number '221890\/Z\/20\/Z' was added in error. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.F.H. and R.E.M. act as scientific consultants for Optima Partners. R.E.M. is an advisor to the Epigenetic Clock Development Foundation. R.F.H. has received consultant fees from Illumina. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10659"}}